Tissue Regenix, a regenerative medtech firm, signs deal with US partner to provide grafts for chronic wound suffers in America.

Leeds spin-out Tissue Regenix has signed a processing partnership with US tissue bank Community Tissue Service, marking a major step forward for the commercialisation strategy of the Yorkshire-based medtech firm.

Founded in 2006, Tissue Regenix is commercialising a biological scaffolding technology which enhances healing in chronic wound conditions. 87% of patients treated with the firm’s medtech product, dCELL, have seen a reduction in the size of their wounds, whereas 60% had their wounds healed completely.

Community Tissue Services currently distributes…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?